mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.0009 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |